Effects of cardiac resynchronization therapy in patients unselected for mechanical dyssynchrony

Area of Science:

• Cardiology
• Heart Failure Management
• Medical Device Therapy

Background:

• Previous studies suggested pre-implant dyssynchrony is crucial for cardiac resynchronization therapy (CRT) response.
• Current clinical guidelines sometimes mandate dyssynchrony assessment before CRT.
• This study questions the necessity of dyssynchrony assessment in CRT patient selection.

Purpose of the Study:

• To evaluate the effectiveness of CRT in heart failure patients not pre-selected for mechanical dyssynchrony.
• To determine if standard selection criteria (NYHA class, LVEF, QRS duration) are sufficient for CRT.

Main Methods:

• 248 heart failure patients (NYHA class III/IV, LVEF ≤35%, QRS ≥120 ms) were assessed before and after CRT.
• Assessments included NYHA class, 6-minute walking distance, and quality of life (Minnesota Living with Heart Failure questionnaire).
• Clinical events, mortality, and hospitalizations were tracked over a median of 720 days.

Main Results:

• Significant improvements were observed in NYHA class (3.25 to 2.06), 6-minute walking distance (232m to 303m), and quality of life (p<0.0001).
• 81% of patients (202/248) met responder criteria (≥1 NYHA class improvement or ≥25% 6MWT improvement).
• Annualized total and cardiovascular mortality rates were 11.7% and 9.89%, respectively.

Conclusions:

• CRT can achieve significant functional and quality of life improvements in heart failure patients selected by NYHA class, LVEF, and QRS duration alone.
• The additional benefit of echocardiographic dyssynchrony assessment for patient selection in CRT remains uncertain.
• Standard clinical and electrocardiographic parameters appear sufficient for guiding CRT decisions.